HONG KONG, June 30, 2017 -- iView Limited (hereinafter referred to as “iView”), a major global pico-projection engine provider, has recently completed its series B funding round valued at over RMB 100 million. CMS Zhiyuan Capital Co., Ltd. (hereinafter referred to as “CMS Zhiyuan Capital”), an investment platform of China Merchants Securities (CMS), was the lead investor during this round of funding.
Founded in 2006, iView is composed of a team of industrial veterans with solid backgrounds in the fields of display, optics and semiconductor, and material science. The company is committed to the research and development of optoelectronics and pico-projection, the commercialization of research and development results, as well as the consumer goods and application in industrial fields. iView has long excelled in the industry and its main clients include well-known providers of projectors, projector phones, and HUD for automotive.
CMS Zhiyuan Capital, the leading investor of this round, thinks highly of the broad prospects of the pico-projector industry and the vast development potential of iView. As one of the major providers of pico-projection core devices, iView ranks top in the industry for its technological strength and market share. While promoting the application of pico-projection in home entertainment, iView also focuses on further achieving high-definition and miniaturization of pico-projectors, launching “Projection +” by integrating with other fields, which include mobile electronics, automobile electronics and smart homes. Now, mature solutions are in place and international and domestic partnerships have been established.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f3a819ed-267e-40da-a358-73fbdf26f6fa
Funds raised from this round will be used primarily for research and development and for boosting industrial capacity, iView will continue to expand the new application scenarios of pico-projection technology in order to meet the corresponding demands. CMS Zhiyuan Capital will share resources, provide iView with comprehensive value-added services, utilize the full range of financial services of the CMS industry chain and foster an early entry into the domestic capital market for the company.
About iView Limited
Headquartered in Hong Kong, iView’s design and production center is located in Shenzhen, China. It is a leading optoelectronic pico-projection component supplier, providing multiple international brands with optoelectronic pico-projectors. The general product series include micro-components embedded in mobile devices, mobile phone driver parts and high-power components for home entertainment and office use. Apart from consumer electronics, products of iView have also been applied to industrial and medical purposes such as head-up display for cars, 3D scanner and printers and medical vein finders.
Contact: Daniel Kong Email: [email protected]


Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Britain Courts Anthropic Amid US Defense Department Dispute
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
First Western Ship Transits Strait of Hormuz Since Iran War Began
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



